{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T23:45:13Z","timestamp":1763768713487,"version":"3.45.0"},"reference-count":21,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100015728","name":"Clinical Science Research and Development","doi-asserted-by":"publisher","award":["Award1\/01CX001549"],"award-info":[{"award-number":["Award1\/01CX001549"]}],"id":[{"id":"10.13039\/100015728","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cardiovascular Revascularization Medicine"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.carrev.2024.12.017","type":"journal-article","created":{"date-parts":[[2024,12,29]],"date-time":"2024-12-29T17:33:00Z","timestamp":1735493580000},"page":"108-112","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Long-term risk of adverse limb outcomes in older patients after endovascular femoral artery revascularization: The Boston femoral artery endovascular revascularization outcomes (Boston FAROUT) study"],"prefix":"10.1016","volume":"80","author":[{"given":"Jay","family":"Khambhati","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Piotr","family":"Sobieszczyk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew C.","family":"Eisenhauer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas M.","family":"Todoran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Scott","family":"Kinlay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.carrev.2024.12.017_bb0005","doi-asserted-by":"crossref","first-page":"e171","DOI":"10.1161\/CIR.0000000000001005","article-title":"Lower extremity peripheral artery disease: contemporary epidemiology, management gaps, and future directions: a scientific statement from the American Heart Association","volume":"144","author":"Criqui","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.carrev.2024.12.017_bb0010","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1001\/jama.2021.2126","article-title":"Lower extremity peripheral artery disease without chronic limb-threatening ischemia: a review","volume":"325","author":"Polonsky","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.carrev.2024.12.017_bb0015","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1093\/eurheartj\/ehx095","volume":"39","author":"Aboyans","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1016\/j.carrev.2024.12.017_bb0020","first-page":"e686","article-title":"2016 AHA\/ACC guideline on the management of patients with lower extremity peripheral artery disease: executive summary: a report of the American College of Cardiology\/American Heart Association task force on clinical practice guidelines","volume":"135","author":"Gerhard-Herman","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.carrev.2024.12.017_bb0025","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1001\/jama.286.11.1317","article-title":"Peripheral arterial disease detection, awareness, and treatment in primary care","volume":"286","author":"Hirsch","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.carrev.2024.12.017_bb0030","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1001\/jama.286.13.1599","article-title":"Leg symptoms in peripheral arterial disease: associated clinical characteristics and functional impairment","volume":"286","author":"McDermott","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.carrev.2024.12.017_bb0035","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1016\/j.jacc.2010.09.053","article-title":"Decline in functional performance predicts later increased mobility loss and mortality in peripheral arterial disease","volume":"57","author":"McDermott","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.carrev.2024.12.017_bb0040","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.115.001946","article-title":"Management of critical limb ischemia","volume":"9","author":"Kinlay","year":"2016","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.carrev.2024.12.017_bb0045","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1161\/CIRCRESAHA.116.303503","article-title":"Endovascular intervention for peripheral artery disease","volume":"116","author":"Thukkani","year":"2015","journal-title":"Circ Res"},{"key":"10.1016\/j.carrev.2024.12.017_bb0050","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.jvs.2005.04.015","article-title":"Preoperative clinical factors predict postoperative functional outcomes after major lower limb amputation: an analysis of 553 consecutive patients","volume":"42","author":"Taylor","year":"2005","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.carrev.2024.12.017_bb0055","first-page":"1331","article-title":"Increased mortality in octogenarians treated for lifestyle limiting claudication","volume":"91","author":"Erben","year":"2018","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.carrev.2024.12.017_bb0060","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/j.jamda.2016.06.004","article-title":"Aging and outcome in patients with peripheral artery disease and critical limb ischemia","volume":"17","author":"Skonetzki","year":"2016","journal-title":"J Am Med Dir Assoc"},{"key":"10.1016\/j.carrev.2024.12.017_bb0065","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1177\/1358863X231174052","article-title":"Patient and limb outcomes 10 years after endovascular revascularization of the superficial femoral artery for peripheral artery disease: the Boston femoral artery endovascular revascularization outcomes (Boston FAROUT) study","volume":"28","author":"Kinlay","year":"2023","journal-title":"Vasc Med"},{"key":"10.1016\/j.carrev.2024.12.017_bb0070","first-page":"611","volume":"86","author":"Jaff","year":"2015","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.carrev.2024.12.017_bb0075","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1056\/NEJMoa2207899","article-title":"Surgery or endovascular therapy for chronic limb-threatening ischemia","volume":"387","author":"Farber","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.carrev.2024.12.017_bb0080","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1161\/CIRCULATIONAHA.115.017719","article-title":"Introduction to the analysis of survival data in the presence of competing risks","volume":"133","author":"Austin","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.carrev.2024.12.017_bb0085","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1016\/j.jvir.2011.08.027","article-title":"Patients\u2019 perspective about risks and benefits of treatment for peripheral arterial disease","volume":"22","author":"Zafar","year":"2011","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.carrev.2024.12.017_bb0090","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1016\/j.jvs.2021.11.057","article-title":"A systematic review of patient-reported outcome measures patients with chronic limb-threatening ischemia","volume":"75","author":"Goodney","year":"2022","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.carrev.2024.12.017_bb0095","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.amjcard.2023.05.053","article-title":"Representativeness of peripheral artery disease randomized clinical trials supporting current guidelines","volume":"201","author":"Castro-Dominguez","year":"2023","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.carrev.2024.12.017_bb0100","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1001\/jamainternmed.2021.2738","article-title":"Longitudinal assessment of safety of femoropopliteal endovascular treatment with paclitaxel-coated devices among Medicare beneficiaries: the SAFE-PAD study","volume":"181","author":"Secemsky","year":"2021","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.carrev.2024.12.017_bb0105","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.ejvs.2017.07.005","article-title":"Amputation rates, mortality, and pre-operative comorbidities in patients revascularised for intermittent claudication or critical limb ischaemia: a population based study","volume":"54","author":"Baubeta Fridh","year":"2017","journal-title":"Eur J Vasc Endovasc Surg"}],"container-title":["Cardiovascular Revascularization Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1553838924007620?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1553838924007620?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T23:42:52Z","timestamp":1763768572000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1553838924007620"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":21,"alternative-id":["S1553838924007620"],"URL":"https:\/\/doi.org\/10.1016\/j.carrev.2024.12.017","relation":{},"ISSN":["1553-8389"],"issn-type":[{"type":"print","value":"1553-8389"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long-term risk of adverse limb outcomes in older patients after endovascular femoral artery revascularization: The Boston femoral artery endovascular revascularization outcomes (Boston FAROUT) study","name":"articletitle","label":"Article Title"},{"value":"Cardiovascular Revascularization Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.carrev.2024.12.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}